207 related articles for article (PubMed ID: 18220513)
1. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
[TBL] [Abstract][Full Text] [Related]
2. Regenerative potential of allopregnanolone.
Wang JM; Liu L; Irwin RW; Chen S; Brinton RD
Brain Res Rev; 2008 Mar; 57(2):398-409. PubMed ID: 17931704
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
Wang JM; Singh C; Liu L; Irwin RW; Chen S; Chung EJ; Thompson RF; Brinton RD
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6498-503. PubMed ID: 20231471
[TBL] [Abstract][Full Text] [Related]
5. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
[TBL] [Abstract][Full Text] [Related]
6. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.
Singh C; Liu L; Wang JM; Irwin RW; Yao J; Chen S; Henry S; Thompson RF; Brinton RD
Neurobiol Aging; 2012 Aug; 33(8):1493-506. PubMed ID: 21803451
[TBL] [Abstract][Full Text] [Related]
7. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
[TBL] [Abstract][Full Text] [Related]
8. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
Irwin RW; Wang JM; Chen S; Brinton RD
Front Endocrinol (Lausanne); 2011; 2():117. PubMed ID: 22654847
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
Irwin RW; Brinton RD
Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
[TBL] [Abstract][Full Text] [Related]
11. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.
Sun C; Ou X; Farley JM; Stockmeier C; Bigler S; Brinton RD; Wang JM
Curr Alzheimer Res; 2012 May; 9(4):473-80. PubMed ID: 22272610
[TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease.
Chen S; Wang T; Yao J; Brinton RD
Neurotherapeutics; 2020 Oct; 17(4):1813-1824. PubMed ID: 32632771
[TBL] [Abstract][Full Text] [Related]
13. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
Irwin RW; Solinsky CM; Loya CM; Salituro FG; Rodgers KE; Bauer G; Rogawski MA; Brinton RD
PLoS One; 2015; 10(6):e0128313. PubMed ID: 26039057
[TBL] [Abstract][Full Text] [Related]
14. Sex steroid levels and AD-like pathology in 3xTgAD mice.
Overk CR; Perez SE; Ma C; Taves MD; Soma KK; Mufson EJ
J Neuroendocrinol; 2013 Feb; 25(2):131-144. PubMed ID: 22889357
[TBL] [Abstract][Full Text] [Related]
15. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential.
Wang JM; Brinton RD
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S11. PubMed ID: 19090984
[TBL] [Abstract][Full Text] [Related]
16. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
Wang T; Yao J; Chen S; Mao Z; Brinton RD
Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
18. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
19. Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice.
Bengtsson SK; Johansson M; Bäckström T; Wang M
J Alzheimers Dis; 2012; 31(1):71-84. PubMed ID: 22495347
[TBL] [Abstract][Full Text] [Related]
20. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.
Giuliani D; Bitto A; Galantucci M; Zaffe D; Ottani A; Irrera N; Neri L; Cavallini GM; Altavilla D; Botticelli AR; Squadrito F; Guarini S
Neurobiol Aging; 2014 Mar; 35(3):537-47. PubMed ID: 24094579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
